The Fight for vaccine diplomacy in the global world of IPR and trademarks

Main Article Content

Minh Le

Abstract

The article aims to shed to light on the topic of vaccine diplomacy and the role of IPR and trademarks in vaccine crisis. The research design is explanatory. The data collection methods and the data analysis methods have been discussed. The quantitative analysis has shown that the “regression model” was insignificant as the higher prices of the vaccines allowed the countries to enjoy the profit as the imposition of IPRs forces the poor countries to buy from the “developed countries”. The qualitative analysis tends to show the imposition of IPRs creates barriers for the less developed countries to have vaccines.

Downloads

Download data is not yet available.

Article Details

Section
Contemporary Issues on Management, Engineering and Economics

References

Abbas, M. Z. (2020). Practical implications of" vaccine nationalism": A short-sighted and risky approach in response to COVID-19 (No. 124). Research Paper. Retrieved from: https://www.econstor.eu/bitstream/10419/232250/1/south-centre-rp-124.pdf

Adikari, A. A. C. J., & Wijesinghe, S. S. (2021). Making Intellectual Property a Common Good to Combat Global Pandemics and the COVID-19 Technology Access Pool (C-TAP): Responding to the Challenges Exerted by Big Pharma and Some High-Income Countries. Vidyodaya Journal of Management, 7(II). Retrieved from: http://journals.sjp.ac.lk/index.php/vjm/article/view/5096/3909

Ahlskog, J. (2020). The Primacy of Method in Historical Research: Philosophy of History and the Perspective of Meaning. Routledge. Retrieved from: https://www.researchgate.net/profile/Jonas-Ahlskog/publication/343501498_The_Primacy_of_Method_in_Historical_Research_Philosophy_of_History_and_the_Perspective_of_Meaning/links/603be192a6fdcc37a85d5141/The-Primacy-of-Method-in-Historical-Research-Philosophy-of-History-and-the-Perspective-of-Meaning.pdf

Asad, S., Qureshi, J., Raheem, M., Shah, T., & Zafar, B. (2021). Vaccine hesitancy in Pakistan is growing: here’s how it can be tackled. LSE COVID-19 Blog. Retrieved from: http://eprints.lse.ac.uk/110584/1/covid19_2021_04_26_its_not_just_about_patents_on_covid_vaccines_why_i.pdf

Banik, N., Chakraborty, D., & Dash, S. K. (2021). IPR waiver in vaccines and opportunities for India: what does the data show? (No. 210).ARTNeT Working Paper Series. Retrieved from: https://www.econstor.eu/bitstream/10419/248847/1/1785218735.pdf

BBC (2021). Covid: US and allies promise one billion jabs for South East Asia. BBC [online]. Retrieved from: https://www.bbc.com/news/world-56381104

Braun, V., & Clarke, V. (2019). Reflecting on reflexive thematic analysis. Qualitative Research in Sport, Exercise and Health, 11(4), 589-597. Retrieved from: https://edisciplinas.usp.br/pluginfile.php/6170845/mod_resource/content/1/Reflecting%20on%20reflexive%20thematic%20analysis%20(2).pdf

Budileanu, C. (2021). Intellectual property in times of COVID-19. Retrieved from: http://cks.univnt.ro/download/cks_2021_articles%252F4_intellectual_property_law%252FCKS_2021_INTELLECTUAL_PROPERTY_LAW_001.pdf

Cammaerts, M. C. (2020). Invertebrates should be given ethical consideration. Animal Sentience, 5(29), 6. Retrieved from: https://www.wellbeingintlstudiesrepository.org/cgi/viewcontent.cgi?article=1587&context=animsent

Cardno, C. (2018). Policy document analysis: A practical educational leadership tool and a qualitative research method. Educational Administration: Theory and Practice, 24(4), 623-640. Retrieved from: https://core.ac.uk/download/pdf/196612718.pdf

CGDEV (2021). Would Exempting COVID-19 Vaccines from Intellectual Property Rights Improve Global Access and Equity?. Cgdev [online]. Retrieved from: https://www.cgdev.org/debate/would-exempting-covid-19-vaccines-intellectual-property-rights-improve-global-access

Chattu, V. K., Singh, B., Kaur, J., & Jakovljevic, M. (2021). COVID-19 vaccine, TRIPS, and global health diplomacy: India’s role at the WTO platform. BioMed Research International, 2021. Retrieved from: https://downloads.hindawi.com/journals/bmri/2021/6658070.pdf

Choudhary, Y., & DED, B. (2021). Intellectual property rights and competition law–a hidden chemistry amidst COVID-19 pandemic. Retrieved from: https://supremoamicus.org/wp-content/uploads/2021/07/YATINDRA-CHOUDHARY.pdf

Clark, E. C., De Rop, F., Jimenez Garcia, I. A., Nogal Macho, A., Alexander Mannette, R., Nova Blanco, J. R., & Vandermeulen, C. (2019). A Systems Map to Elucidate the Factors Influencing Vaccine Coverage. Transdisciplinary Insights, 3(1), 115-150. Retrieved from: https://www.ingentaconnect.com/contentone/leuven/ti/2019/00000003/00000001/art00005?crawler=true&mimetype=application/pdf

Crombie, J. (2021). Intellectual property rights trump the right to health: Canada’s Access to Medicines Regime and TRIPs flexibilities in the context of Bolivia’s quest for vaccines. Journal of Global Ethics, 1-14. Retrieved from: https://www.tandfonline.com/doi/pdf/10.1080/17449626.2021.1993452

De Menezes, H. Z. (2021). The TRIPS waiver proposal: an urgent measure to expand access to the COVID-19 vaccines (No. 129). Research Paper. Retrieved from: https://www.econstor.eu/bitstream/10419/248628/1/RP-129.pdf

Eriksen, S. S. (2020). China, India and the political economy of medical supplies. NUPI Covid-19 Brief. Retrieved from: https://nupi.brage.unit.no/nupi-xmlui/bitstream/handle/11250/2653254/COVID-19_BRIEF_4_Eriksen.pdf?sequence=2

Ferchen, M. (2021). Towards' extreme competition': Mapping the contours of US-China relations. Retrieved from: https://merics.org/sites/default/files/2021-03/MERICS%20ChinaMonitor%2068%20US%20China%20Biden%20final2.pdf

Hunter, D., McCallum, J., & Howes, D. (2019). Defining exploratory-descriptive qualitative (EDQ) research and considering its application to healthcare. Journal of Nursing and Health Care, 4(1).https://eprints.gla.ac.uk/180272/7/180272.pdf

Ito, B. (2021). Impacts of the Vaccine Intellectual Property Rights Waiver on Global Supply. VOXeu/CEPR. August 8, 2021. Retrieved From: https://voxeu.org/article/impacts-vaccine-intellectual-property-rights-waiver-global-supply

Jecker, N. S., & Atuire, C. A. (2021). What’s yours is ours: waiving intellectual property protections for COVID-19 vaccines. Journal of Medical Ethics, 47(9), 595-598. Retrieved From: https://jme.bmj.com/content/medethics/47/9/595.full.pdf

Kanat-Maymon, Y., Elimelech, M., & Roth, G. (2020). Work motivations as antecedents and outcomes of leadership: Integrating self-determination theory and the full range leadership theory. European Management Journal, 38(4), 555-564. Retrieved From: https://selfdeterminationtheory.org/wp-content/uploads/2021/01/2020_KanatMaymonElimelechRoth_WorkMotivations.pdf

Marceau, G., & Parwani, P. (2021). COVID-19 and international trade: The role of the WTO in fighting the pandemic and building back better. Global Trade and Customs Journal, 16(7/8). Retrieved from: https://archive-ouverte.unige.ch/unige:154568/ATTACHMENT01

Mercurio, B. (2021). WTO Waiver from Intellectual Property Protection for COVID-19 Vaccines and Treatments: A Critical Review. Available at SSRN 3789820. Retrieved from: https://www.vjil.org/s/Mercurio-WTO-Waiver_Sargsyan-Final-Review-bcm-081121.pdf

Mešević, I. R. (2021). Access to Covid-19 Vaccine: Patents vs. People?. International and Comparative Law Review, 21(1), 43-78. Retrieved from: https://sciendo.com/pdf/10.2478/iclr-2021-0002

Moon, K., Blackman, D. A., Adams, V. M., Colvin, R. M., Davila, F., Evans, M. C., & Wyborn, C. (2019). Expanding the role of social science in conservation through an engagement with philosophy, methodology, and methods. Methods in Ecology and Evolution, 10(3), 294-302. Retrieved From: https://besjournals.onlinelibrary.wiley.com/doi/pdf/10.1111/2041-210X.13126

Neuendorf, K. A. (2018). Content analysis and thematic analysis. In Advanced research methods for applied psychology (pp. 211-223). Routledge. Retrieved From: https://www.academia.edu/download/60533259/_Paula_Brough__Advanced_Research_Methods_for20190909-80496-18tab5h.pdf#page=224

Neumann, P. J., Cohen, J. T., Kim, D. D., & Ollendorf, D. A. (2021). Consideration Of Value-Based Pricing For Treatments And Vaccines Is Important, Even In The COVID-19 Pandemic: Study reviews alternative pricing strategies (cost-recovery models, monetary prizes, advanced market commitments) for COVID-19 drugs, vaccines, and diagnostics. Health Affairs, 40(1), 53-61. Retrieved From: https://heatinformatics.com/sites/default/files/images-videosFileContent/hlthaff.2020.01548.pdf

Novotná, T. (2021). The European Union and Korea between the US and China: Geopolitical aspects of connectivity from the soft to hard power approaches (No. 2021-11).

Oser, A. (2021). The COVID-19 Pandemic: Stress Test for Intellectual Property and Pharmaceutical Laws. GRUR International, 70(9), 846-854. Retrieved From: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344505/

Ranjan, P. (2021). The Case for Waiving Intellectual Property Protection for Covid-19 Vaccines. Retrieved From: https://www.sipotra.it/wp-content/uploads/2021/04/Issue-Brief-No.-456-April-2021.pdf

Sekalala, S., Forman, L., Hodgson, T., Mulumba, M., Namyalo-Ganafa, H., & Meier, B. M. (2021). Decolonising human rights: how intellectual property laws result in unequal access to the COVID-19 vaccine. BMJ Global Health, 6(7), e006169. Retrieved from: https://scholar.google.com/scholar?output=instlink&q=info:DywcFe3pPjkJ:scholar.google.com/&hl=en&as_sdt=0,5&as_ylo=2018&scillfp=9728004947217879170&oi=lle

Sharma, J., & Varshney, S. K. (2021). India’s vaccine diplomacy aids global access to COVID-19 jabs. Retrieved From: https://www.nature.com/articles/nindia.2021.31

Singh, B., Chattu, V. K., Kaur, J., Mol, R., Gauttam, P., & Singh, B. (2022). COVID-19 and Global Distributive Justice:‘HealthDiplomacy’of India and South Africa for the TRIPS waiver. Journal of Asian and African Studies, 00219096211069652. Retrieved From: https://journals.sagepub.com/doi/pdf/10.1177/00219096211069652

statista.com, (2021), reported-cost-per-dose-of-covid-19-vaccines. Retrieved on 27 January from: https://www.statista.com/chart/23658/reported-cost-per-dose-of-covid-19-vaccines/

Su, Z., McDonnell, D., Li, X., Bennett, B., Šegalo, S., Abbas, J., & Xiang, Y. T. (2021). COVID-19 Vaccine Donations—Vaccine Empathy or Vaccine Diplomacy?A Narrative Literature Review. Vaccines, 9(9), 1024. Retrieved From: https://www.mdpi.com/2076-393X/9/9/1024/pdf

Thambisetty, S. (2021). It’s not just about patents on COVID vaccines: why I am not celebrating World Intellectual Property Day. LSE COVID-19 Blog. Retrieved from: http://eprints.lse.ac.uk/110583/1/covid19_2021_04_26_its_not_just_about_patents_on_covid_vaccines_why_i.pdf

WHO (2021). Attacks on health care in the context of COVID-19. WHO [online]. Retrieved from: https://www.who.int/news-room/feature-stories/detail/attacks-on-health-care-in-the-context-of-covid-19

Woiceshyn, J., & Daellenbach, U. (2018). Evaluating inductive vs deductive research in management studies: Implications for authors, editors, and reviewers. Qualitative Research in Organizations and Management: An International Journal. https://www.researchgate.net/profile/Jaana-Woiceshyn-2/publication/324596659_Evaluating_Inductive_versus_Deductive_Research_in_Management_Studies_Implications_for_Authors_Editors_and_Reviewers/links/5b78d9aa92851c1e121f7477/Evaluating-Inductive-versus-Deductive-Research-in-Management-Studies-Implications-for-Authors-Editors-and-Reviewers.pdf